RaySearch actively working with its partner Nucletron on four tenders.

About RaysearchRaySearch Laboratories is a medical device company RaySearch software solutions for improved radiation therapy of cancer. RaySearch license agreements with leading license agreements with leading partners such as Philips, Nucletron, IBA Dosimetry and TomoTherapy. Eight products have been released and RaySearch software is used in over 1,300 clinics in more than 30 countries. In addition, license agreements cover more than 15 other products that are expected in the coming years on the market. RaySearch was as a as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment of the OMX Nordic Exchange in Stockholm.. Proton therapy a priority development RaySearch is involved areas and the companies in talks about a number of business opportunities in the field For example, RaySearch actively working with its partner Nucletron on four tenders.

You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at Kaiser health news. Modern Healthcare: is law as part of the new health card HHS distribution help $ 68,000 in grants to people to navigate their health and long – term care insurance options The grants will go community – to states, territories, tribes and organizations. Help for seniors, persons with disabilities and their carers, more informed decisions about their health and long-term care. Particular, the funds will be used to help to understand families, their Medicare and Medicaid benefits, navigate options for long-term care and support the the back transition from nursing or rehabilitation facilities back home the supports the supports in place, that the transition is successful, according to according to HHS , The grants in four areas: Medicare coverage.More details can be found:.. The global pharmaceuticals market likely to grow to $ 929,000 in 2012, an equal CAGR of 5.5 percent in the next four years. To 142 – page study said future sales growth remain limited by high a prescription drug co-payments Scheme Policy load, the increasing availability of generic drugs and an a lack of new blockbusters for replaced the leading products in scheduled loose patents. Pharmaceutical Market trend, 2008 – 2012 – Key market forecast and opportunities for growth is available from URCH Publishing.

Be predicted to overtake Pfizer is To World’s Largest Pharmaceutical Co. From 2012 – URCH Publishing.

The are large changes in global pharmaceutical market and the most important changes in the top ten enterprises list of until 2012, says a new report by URCH Publishing, a leading pharmaceutical business information.